Oncology

A new study of nearly 129,000 adults has revealed that common midlife comorbidities, such as respiratory and cardiovascular conditions, are associated with an increased risk of cancer and cancer-related death.

A recent multi-centre study reveals taxane-based chemotherapy is linked to markedly better one-year survival in advanced triple-negative breast cancer with genomic instability, compared to platinum-based treatments.

A new study has projected that radiation exposure from computed tomography (CT) scans in the United States will result in approximately 103,000 future cancers.

New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.

New research presented at ESMO Breast 2025 shows that alcohol consumption raises the risk of developing breast cancer, particularly hormone receptor-positive types, but does not appear to worsen survival or recurrence in those already diagnosed.

New data from ESMO Breast 2025 indicate that inherited DNA repair mutations could affect the effectiveness of CDK4/6 inhibitors in treating advanced breast cancer, with mutation carriers showing lower response rates and shorter survival trends.

New data presented at ESMO Breast 2025 show that short-course radiotherapy offers similar survival outcomes to conventional treatment following surgery and nodal irradiation for breast cancer.

Research shows that regular physical activity can help close the survival gap for stage III colon cancer, with those who exercise achieving survival rates similar to the general population.